Literature DB >> 33111190

Neurotoxic effects in zebrafish embryos by valproic acid and nine of its analogues: the fish-mouse connection?

Katharina Brotzmann1, André Wolterbeek2, Dinant Kroese2, Thomas Braunbeck3.   

Abstract

Since teratogenicity testing in mammals is a particular challenge from an animal welfare perspective, there is a great need for the development of alternative test systems. In this context, the zebrafish (Danio rerio) embryo has received increasing attention as a non-protected embryonic vertebrate in vivo model. The predictive power of zebrafish embryos for general vertebrate teratogenicity strongly depends on the correlation between fish and mammals with respect to both overall general toxicity and more specific endpoints indicative of certain modes-of-action. The present study was designed to analyze the correlation between (1) effects of valproic acid and nine of its analogues in zebrafish embryos and (2) their known neurodevelopmental effects in mice. To this end, zebrafish embryos exposed for 120 h in an extended version of the acute fish embryo toxicity test (FET; OECD TG 236) were analyzed with respect to an extended list of sublethal endpoints. Particular care was given to endpoints putatively related to neurodevelopmental toxicity, namely jitter/tremor, deformation of sensory organs (eyes) and craniofacial deformation, which might correlate to neural tube defects caused by valproic acid in mammals. A standard evaluation of lethal (LC according to OECD TG 236) and sublethal toxicity (EC) merely indicated that four out of ten compounds tested in zebrafish correlate with positive results in mouse in vivo studies. A detailed assessment of more specific effects, however, namely, jitter/tremor, small eyes and craniofacial deformation, resulted in a correspondence of 75% with in vivo mouse data. A refinement of endpoint analysis from an integration of all observations into one LCx or ECx data (as foreseen by current ecotoxicology-driven OECD guidelines) to a differential evaluation of endpoints specific of selected modes-of-action thus increases significantly the predictive power of the zebrafish embryo model for mammalian teratogenicity. However, for some of the endpoints observed, e.g., scoliosis, lordosis, pectoral fin deformation and lack of movement, further experiments are required for the identification of underlying modes-of-action and an unambiguous interpretation of their predictive power for mammalian toxicity.

Entities:  

Keywords:  Analogues; Correlation fish/mouse; Embryo; Neural tube defects; Neurotoxicity; Valproic acid; Zebrafish

Year:  2020        PMID: 33111190      PMCID: PMC7870776          DOI: 10.1007/s00204-020-02928-7

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  72 in total

1.  Zebrafish embryotoxicity test for developmental (neuro)toxicity: Demo case of an integrated screening approach system using anti-epileptic drugs.

Authors:  Anna Beker van Woudenberg; Cor Snel; Eke Rijkmans; Didima de Groot; Marga Bouma; Sanne Hermsen; Aldert Piersma; Aswin Menke; André Wolterbeek
Journal:  Reprod Toxicol       Date:  2014-08-08       Impact factor: 3.143

Review 2.  Zebrafish in Toxicology and Environmental Health.

Authors:  Kathryn Bambino; Jaime Chu
Journal:  Curr Top Dev Biol       Date:  2016-12-21       Impact factor: 4.897

3.  Toxicity of silver nanoparticles in zebrafish models.

Authors:  P V Asharani; Yi Lian Wu; Zhiyuan Gong; Suresh Valiyaveettil
Journal:  Nanotechnology       Date:  2008-05-14       Impact factor: 3.874

4.  Prickle1 is required for EMT and migration of zebrafish cranial neural crest.

Authors:  Kamil Ahsan; Noor Singh; Manuel Rocha; Christina Huang; Victoria E Prince
Journal:  Dev Biol       Date:  2019-02-02       Impact factor: 3.582

5.  Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants.

Authors:  Stephane Berghmans; Julia Hunt; Alan Roach; Paul Goldsmith
Journal:  Epilepsy Res       Date:  2007-05-07       Impact factor: 3.045

6.  Ethanol exposure alters zebrafish development: a novel model of fetal alcohol syndrome.

Authors:  Joseph Bilotta; Jalynn A Barnett; Laura Hancock; Shannon Saszik
Journal:  Neurotoxicol Teratol       Date:  2004 Nov-Dec       Impact factor: 3.763

7.  Fishing for teratogens: a consortium effort for a harmonized zebrafish developmental toxicology assay.

Authors:  Jonathan S Ball; Donald B Stedman; Jedd M Hillegass; Cindy X Zhang; Julie Panzica-Kelly; Aleasha Coburn; Brian P Enright; Belen Tornesi; Hamid R Amouzadeh; Malcolm Hetheridge; Anne-Lee Gustafson; Karen A Augustine-Rauch
Journal:  Toxicol Sci       Date:  2014-02-04       Impact factor: 4.849

8.  Development of a zebrafish embryo teratogenicity assay and quantitative prediction model.

Authors:  Kimberly C Brannen; Julieta M Panzica-Kelly; Tracy L Danberry; Karen A Augustine-Rauch
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2010-02

9.  Large-scale assessment of the zebrafish embryo as a possible predictive model in toxicity testing.

Authors:  Shaukat Ali; Harald G J van Mil; Michael K Richardson
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

10.  Nodal signaling is required for closure of the anterior neural tube in zebrafish.

Authors:  Allisan Aquilina-Beck; Kristine Ilagan; Qin Liu; Jennifer O Liang
Journal:  BMC Dev Biol       Date:  2007-11-08       Impact factor: 1.978

View more
  2 in total

1.  The Validity of Brine Shrimp (Artemia Sp.) Toxicity Assays to Assess the Ecological Function of Marine Natural Products.

Authors:  Weili Chan; Abigail E P Shaughnessy; Cedric P van den Berg; Mary J Garson; Karen L Cheney
Journal:  J Chem Ecol       Date:  2021-03-13       Impact factor: 2.626

2.  Potential of the zebrafish (Danio rerio) embryo test to discriminate between chemicals of similar molecular structure-a study with valproic acid and 14 of its analogues.

Authors:  Katharina Brotzmann; Sylvia E Escher; Paul Walker; Thomas Braunbeck
Journal:  Arch Toxicol       Date:  2022-08-03       Impact factor: 6.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.